Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020599

« Back to Dashboard

NDA 020599 describes RILUTEK, which is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from three suppliers. Additional details are available on the RILUTEK profile page.

The generic ingredient in RILUTEK is riluzole. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the riluzole profile page.

Summary for 020599

Tradename:	RILUTEK
Applicant:	Covis Pharma Bv
Ingredient:	riluzole
Patents:	0
Therapeutic Class:	Central Nervous System Agents
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020599

Ingredient-type	Benzothiazoles

Medical Subject Heading (MeSH) Categories for 020599

Anticonvulsants
Excitatory Amino Acid Antagonists
Neuroprotective Agents

Suppliers and Packaging for NDA: 020599

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
RILUTEK	riluzole	TABLET;ORAL	020599	NDA	KAISER FOUNDATION HOSPITALS	0179-0143	N	0179-0143-70
RILUTEK	riluzole	TABLET;ORAL	020599	NDA AUTHORIZED GENERIC	Rising Pharmaceuticals, Inc.	64980-191	N	64980-191-06

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	50MG
Approval Date:	Dec 12, 1995	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020599

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Covis Pharma Bv	RILUTEK	riluzole	TABLET;ORAL	020599-001	Dec 12, 1995	➤ Try a Free Trial	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.